| 
Consumer Credit Insurance Association May 28, 2004
 Office of the Comptroller of the Currency250 E Street, S.W.
 Public Information Room
 Mail Stop 1-5
 Washington, D.C. 20219
 Attention: Docket No. 04-09
 Jennifer J. JohnsonSecretary
 Board of Governors of the Federal Reserve
 System
 20th Street and Constitution Avenue, N.W.
 Washington, D.C. 20551
 Attention: Docket No. R-1188
 Robert E. FeldmanExecutive Secretary
 Attention: Comments
 Federal Deposit Insurance Corporation
 550 17th Street, N.W.
 Washington, D.C. 20429
 Re: RIN 3064-AC81
 
 Regulation CommentsChief Counsel’s Office
 Office of Thrift Supervision
 1700 G Street, N.W.
 Washington, D.C. 20552
 Attention: Docket No. 2004-16
 Becky BakerSecretary of the Board
 National Credit Union Administration
 1775 Duke Street
 Alexandria, Virginia 22314-3428
 Re: 12 CFR Part 717
 
 Dear Sirs and Madams:  These comments are submitted on behalf of the Consumer Credit 
        Insurance Association (CCIA), a national trade association of more than 
        140 insurance companies engaged in the business of insuring consumer 
        credit transactions. A number of our member companies also provide 
        administrative services to financial institutions for their debt 
        protection programs. Accordingly, CCIA is dedicated to preserving, 
        promoting, and enhancing the availability, utility, and integrity of 
        insurance and related debt protection products delivered in connection 
        with financial transactions.  We welcome the opportunity to offer comment on the proposed 
        regulations implementing section 411 of the Fair and Accurate Credit 
        Transactions Act of 2003 (FACT Act). Our comments are limited to 
        creditors’ use of medical information in connection with credit 
        insurance, debt cancellation contracts (DCCs), and debt suspension 
        agreements (DSAs).  CCIA - Page 2 - 6/1/2004  We recommend a specific and equal exception to the prohibition on 
        such use of medical information to eliminate the ambiguity and 
        inconsistency we perceive between the treatment of credit insurance, 
        DCCs, and DSAs under the proposed regulations.  Exceptions (A) and (B) in Subpart D-Medical Information 
        §__.30(a)(2)(i) (defining “eligibility, or continued eligibility for 
        credit”) are inconsistent as to insurance products and such debt 
        protection products as DCCs and DSAs. Exception (A) permits use of 
        medical information to determine qualification or fitness to be offered 
        “… insurance products, or other non-credit products or services.” 
        Exception (B) permits the use of medical information in determining 
        whether benefits are triggered for “…a debt cancellation contract, debt 
        suspension agreement, credit insurance product, or similar forbearance 
        practice or program….”DCCs and DSAs should be included in exception (A), 
        which permits use of medical information to determine qualification to 
        be offered particular products. Equally, the general term “insurance 
        products” should be included in exception (B), which permits the use of 
        medical information to determine the triggering of benefits. This change 
        would provide a consistent treatment for both credit insurance and DCCs 
        and DSAs.  Credit Insurance and DCC and DSA Programs As Functional 
        Equivalents  Credit insurance and DCCs and DSAs both serve to protect consumer 
        debt and credit. Since they function equivalently they should be treated 
        equivalently. While a number of credit lenders have moved from credit 
        insurance programs to DCC and DSA programs, many banks continue to use 
        both programs. It would impose an operational hardship for credit 
        lenders using both types of programs to comply with two separate 
        regulatory requirements regarding use of medical information: one to 
        determine qualification for the insurance product and another to 
        determine the benefits trigger for both the insurance product and the 
        debt protection product. Moreover, there is no evident justification or 
        stated reason why DCCs and DSAs are not contained in both exclusions. 
        Section 411 of the FACT Act expressly empowers the federal banking 
        agencies and the National Credit Union Administration to except from the 
        prohibition on the use of medical information those transactions that 
        are “…necessary and appropriate to protect the legitimate operational, 
        transactional, risk, consumer, and other needs.” Therefore, consistent 
        exceptions for use of medical information for determining “qualification 
        or fitness for” and “triggering of provisions” of both credit insurance 
        and DCCs and DSAs are within the agencies’ authority.  References to Insurance As Opposed to Credit Insurance Create 
        Ambiguity  Credit insurance is a narrowly defined type of insurance under state 
        statutes and regulations. Most states have enacted the NAIC Consumer 
        Credit Insurance Model Act and the Consumer Credit Insurance Model 
        Regulation. It is necessarily subsumed under the general term, 
        insurance. Again, there is no evident justification to use the general 
        term “insurance” in exception (A) and the specific term “credit 
        insurance” in exception (B). Creditors may offer other types of 
        insurance than credit insurance, such as term life, homeowners, 
        automobile, and other personal lines coverage. Creditors would have a 
        legitimate reason to use medical information to determine benefits 
        triggers in those types of insurance as well as credit insurance.  Therefore, the general term “insurance product” should be used in 
        both exception (B), as well as in exception (A). This would remove any 
        ambiguity in using a general term in one instance and a specific term in 
        the other.  We offer the following recommendations:  
1. Move the exclusions, with suggested change in wording, currently 
          in the definition of Eligibility to the Specific Exceptions for 
          Obtaining and Using Medical Information section. 2. If the exclusions are not moved and remain in the definition of 
          Eligibility, change the wording of exclusions A and B and their 
          applicability to DCCs and DSAs to be consistent with and to reflect 
          Section 411 of the FACT Act.
 The suggested alternative language would be as follows:  Current __.30(d)(vii) “As otherwise permitted by order of the OCC” 
        moved to become new (viii) and replaced with:  
(vii) To the extent such information is obtained for purposes of
           
(A) The consumer’s qualification or fitness to be offered 
            employment, debt cancellation contracts, debt suspension 
            agreements, insurance products, or other non-credit products or 
            services;  (B) Any determination of whether the provisions of a debt 
            cancellation contract, debt suspension agreement, credit 
            insurance product, or similar forbearance practice or program are 
            triggered;  (C) Authorizing, processing, or documenting a payment or 
            transaction on behalf of the consumer in a manner that does not 
            involve a determination of the consumer’s eligibility, or continued 
            eligibility, for credit; or  (D) Maintaining or servicing the consumer’s account in a manner 
            that does not involve a determination of the consumer’s eligibility 
            or continued eligibility, for credit.  We appreciate the opportunity to provide these comments.  Yours truly,
 Kathleen J. WhartonConsumer Credit Insurance Association
 542 South Dearborn St, Suite 400
 Chicago, IL  60605
 
 |